Lipapa, Zyrex .
HRN: 25-40-54 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/19/2024
AMPICILLIN 250MG (VIAL)
11/19/2024
11/26/2024
IV
205mg
Q6h
PCAP C
Waiting Final Action
11/19/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
11/19/2024
11/25/2024
IV
60
Q24Hrs
PCAP
Waiting Final Action